BackRegeneRx Biopharmaceuticals Overview

RegeneRx Biopharmaceuticals Other Assets

RegeneRx Biopharmaceuticals's other assets is $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average / median

Loading

RegeneRx Biopharmaceuticals Other Assets History

Loading

RegeneRx Biopharmaceuticals vs. peers: Other Assets Comparison

Loading

RegeneRx Biopharmaceuticals Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

RegeneRx Biopharmaceuticals (RGRX) FAQ

RegeneRx Biopharmaceuticals (RGRX) currently reports a other assets of $0 as of September 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore RegeneRx Biopharmaceuticals's other assets history and peer comparisons.

RegeneRx Biopharmaceuticals's other assets changed from $0 to $0 (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RegeneRx Biopharmaceuticals reported $0 in other assets as of September 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for RegeneRx Biopharmaceuticals, and consider following RGRX for alerts when major investors trade the stock.

RegeneRx Biopharmaceuticals is classified in the Healthcare sector. On other assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RGRX with unrelated industries.